CV Therapeutics, Inc.
Records under this name other than the patents CV Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,956,179 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · High confidence | In force | High confidence | |
| US 8,106,183 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,268,988 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,524,883 | Monohydrate of (1-{9-[(4S,2R,3R,5R)-3,4-Dihydroxy-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6-Aminopurin-2-YL}PYRAZOL-4-YL)-N-METHYLCARBOXAMIDE Formerly held In force · Medium confidence | In force | Medium confidence | |
| US RE47,301 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,671,192 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · High confidence | In force | High confidence | |
| US 7,732,595 | Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,625,881 | Prodrugs of A2B Adenosine Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 7,795,268 | Method of Treating Hepatic Disease Using A2B Adenosine Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 9,045,428 | Substituted Heterocyclic Compounds Formerly held In force · Low confidence | In force | Low confidence |